Clinical Trials Directory

Trials / Unknown

UnknownNCT03465215

Evaluation of Stricturing Crohn's Disease Using Digital Holographic Microscopy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
29 (estimated)
Sponsor
University Hospital Muenster · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Crohn's Disease (CD) patients, belonging to Inflammatory Bowel Disease (IBD), frequently suffer from uncontrolled intestinal inflammation. This can lead to severe disease complications requiring hospitalization. Up to 50% of all CD patients develope intestinal strictures. Intestinal strictures can be subdivided into predominantly inflammatory and predominantly fibrotic types. This subclassification in different types of strictures is important for clinical decision making: patients with predominantly fibrotic strictures would undergo surgery or interventional endoscopic treatment and patients with predominantly inflammatory strictures would be treated anti-inflammatory. To determining the degree of fibrosis and inflammation in CD strictures remains difficult. Digital holographic microscopy (DHM) is a new imaging approach belonging to the group of quantitative phase imaging. DHM enables stain-free quantitative phase contrast imaging and provides the determination of an refractive index which directly correlated to tissue density. This study aims to evaluate DHM for assessing the degree of fibrosis and inflammation in surgical specimen from patients with stricturing CD. The investigators collect full thickness surgical resection specimen from 29 patients with symptomatic CD strictures. More detailed, the investigators collect full thickness surgical resection specimen out of stenotic and non-stenotic bowel segments from each patient. For primary purposes, the investigators analyze the obtained tissue using DHM and compare differences of the refractive index, determined by DHM, between stenotic and non-stenotic parts of the intestinal wall. For secondary purposes, the investigators will correlate the findings made by DHM with a detailed analysis by a histopathologist using a scoring system (Goldstandard) to determine the degree of fibrosis and inflammation in the samples.

Conditions

Interventions

TypeNameDescription
DEVICEDigital holographic microscopyTissue obtained from CD patients will be analyzed using digital holographic microscopy. Results will be compared between non-stenotic and stenotic tissue of the intestinal wall of CD patients.

Timeline

Start date
2018-02-01
Primary completion
2020-02-01
Completion
2020-08-01
First posted
2018-03-14
Last updated
2018-03-26

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03465215. Inclusion in this directory is not an endorsement.